Several studies have investigated prevalence of
respiratory symptoms in the HIV-infected population. Before anti-retroviraltherapy (ART), there was a high prevalence of dyspnea and cough in this
population.
These studies showed low CD4 cell counts, history of smoking and
intravenous drug use, and previous history of pneumonia were associated with
increased risk of dyspnea and cough symptoms. More recent studies in the
post-ART era show that respiratory symptoms continue to be common in HIV-infected
individuals, with the prevalence of cough ranging from 23-37% and prevalence of
dyspnea ranging from 16-44%. Read more>>>>>>>>>>>>>>
No comments:
Post a Comment